期刊文献+

MMP-14、MMP-2、TIMP-2在胃癌组织中表达及意义 被引量:6

Espression and significance of MMP-14 and MMP-2,TIMP-2 in gastric cancer
下载PDF
导出
摘要 目的:探讨基质金属蛋白酶(Metalloproteinase,MMP)-14、-2、基质金属蛋白酶组织抑制因子(Tissue inhibitor ofmetalloproteinase,TIMP)-2在胃癌、癌旁组织及胃溃疡中的表达情况及相互关系。方法:用免疫组织化学方法(SP法)检测30例胃癌手术病人及20例胃镜活检胃溃疡病人中MMP-14、MMP-2、TIMP-2的表达。结果:(1)胃癌组织中,TIMP-2、MMP-2及MMP-14表达阳性率分别为43.3%、76.7%、53.3%,胃癌癌旁组织中分别为56.7%、46.7%和40%,胃溃疡组织中分别为70%、45%和30%。(2)在胃癌中,TIMP-2的阳性表达与癌旁组织及胃溃疡组织比较有统计学差异(P<0.01),MMP-2阳性表达与溃疡组织之间比较有统计学差异(P<0.05)。(3)在癌组织中,MMP-2、MMP-14和TIMP-2表达均与浆膜是否受侵、淋巴结有无转移和TNM临床分期密切相关(P<0.05)。(4)双变量相关分析,在胃癌组织中,MMP-14和MMP-2阳性表达呈正相关(rs=0.447,P>0.05),而TIMP-2阳性表达与前两者均呈显著负相关(rs=-1.0,P<0.01)。结论:(1)MMP-1在胃癌中高表达。(2)MMP-14和MMP-2阳性表达呈正相关,是胃癌的侵袭转移性因素之一。(3)MMP-14表达上调的同时激活了更多的MMP-2,增加了胃癌向周围组织侵袭转移的能力。 Objective:To detect the expression of MMP-14,MMP-2 and TIMP-2 in gastric ulcer tissues, gastric cancer and tissues around gastric cancer. Methods:The expression of MMP-14, MMP-2,and TIMP-2 were detected by S-P immunohistochemistry in gastric ulcer tissues,gastric cancer tissues and around tissues from operated patients of gastric cancer (n=30) and gastric ulcer patients(n=20)who were diagnosed by stomach lens. Results:(1) The expression rates of TIMP-2, MMP-2 and MMP-14was 43.3%,76.7% and 53.3% respectively in gastric cancer tissues and 56.7%,46.7% and 40%in tissues around it,but 70%,45% and 30% in gastric ulcer tissues. (2) The expression of TIMP-2 in gastric cancer was lower than that in tissues or that in gastric ulcer tissues(P〈0.01 ).The expression of MMP-2 in gastric cancer was higher then that of gastric ulcer (P〈0.05).(3) The expression of MMP-2,MMP-14 and TIMP-2 in gastric cancer tissues were closely correlated to the serosa invaded, lymph node metastasis and TNM stages(P〈0.05). (4) There was positive correlation between the expression of MMP-2 and MMP-14 in gastric cancer(rs=0.447,P〉0.05).The expression of TIMP-2 was negatively correlated with the expression of MMP-2 or MMP-14(rs=-1.0,P〈0.01)in gastric cancer. Conclusions:(1)The MMP-14 in gastric cancer is over expressed.(2)MMP -14 was one of invading and metastasis factors in gastric cancer and could judge prognosis of it. (3)The high expression of MMP-14 and MMP-2 showed that increased expression of MMP-14 resulted in more MMP-2 activation and increased ability of invading and metastasis in the tissues around gastric cancer. (4)TIMP-2 plays an important role in resisting MMP-14 in gastric cancer and gastric ulcer tissues.
出处 《重庆医科大学学报》 CAS CSCD 2008年第7期799-802,810,共5页 Journal of Chongqing Medical University
关键词 胃癌 MMP-14 MMP-2 TIMP-2 Gastric cancer MMP- 14 MMP-2 TIMP-2
  • 相关文献

参考文献13

  • 1Woodhouse EC,Chuaqui RF,Liotta LA. General mechanisms of metastasis[J]. Cancer, 1997;80(8): 1529-1536.
  • 2Poulson R,Pignatelli G. Stromal expression of 72ku type Ⅳ collagens and TIMP-2 mRNAs in collected neoplasia[J]. Am J Pathol, 1992; 142(2 ) : 389-397.
  • 3Nagase H. Activation mechanisms of matrix metalloproteinase[J]. Biol Chem, 1997 ; 378 ( 3-4 ) : 151- 160.
  • 4Yoshimoto M,Itoh F,Yamamoto H,et al. Expression of MMP-7 (PUMP-1)mRNA in human colorectal cancers[J]. Int J Cancer,1993; 54(4) : 614-618.
  • 5Sato H, Seiki M. Membrane-type matrix metalloproteinase ( MT-MMPs ) in tumor metastasis[J]. J Biochem (Tokyo), 1996 ; 119 (2) :209-215.
  • 6Murray GI,Duncan ME,Arbuckle E,et al. Matrix metalloproteinase and their inhi-bittors in gastric cancer[J]. Gut, 1998 ;43(6) : 791-797.
  • 7高嵋,姜汉国,唐慰萍,李飞虹,蔡琼珍.基质金属蛋白酶-2在胃癌中的表达及其对癌微血管生成和转移的影响[J].广东医学院学报,2004,22(1):8-9. 被引量:5
  • 8Allgayer H,Babic R,Grutzner KU,et al. Tumor-associatede proteases and inhibitors in gastric cancer:analysis of prognostic impact and individual risk protease patterns[J]. Clin Exp Metastasis,1998;16(1):62-73.
  • 9Monig SP,Baldus SE,Hennecken JK,et al. Expression of MMP-2 associated with progression and lymph node metastasis of gastric carcinoma[J]. Histopathology, 2001 ; 39(4 ) : 597-602.
  • 10Ichikawa Y,Ishikawa T,Tanaka K,et al. Extracellular matrix degradation enzymes:important factors in liver metastasis of colorectal cancer and good targets for anticancer metastasis therapy[J]. Nippon Geka Gakkai Zasshi, 2001 ; 102( 3 ) : 376.

二级参考文献9

  • 1Monig SP,Zirbes TK,Schroder W,et al.Staging of gastric cancer:correlation of lymph node size and metastatic infiltration[J].Am J Roentgenol,1999,172(2):365-367.
  • 2Maatta M,Soini Y,Liakka A,et al.Differential expression of matrix metalloproteinase MMP-2,MMP-9,and membrane type 1-MMP in human hepatocellular and pancreatic adenocarcinomas:implication for tumor progression and clinical prognoss[J].Clin Cancer Res,2000,
  • 3Westermarck J,Kahari VM.Regulation of matrix metalloproteinase expression in tumor invasion[J].FASEB J,1999,13(8):781-792.
  • 4Bosari S,Delelli RA,Healtley GL,et al.Microvessel quantitation and progress in invasive breast carcinoma[J].Hum Pathol,1992,23(4):755-763.
  • 5Allgayer H,Babic R,Grutzner KU,et al.Tumor-associated proteases and inhibitors in gastric cancer:analysis of prognostic impact and individual risk protease patterns[J].Clin Exp Metastasis,1998,16(1):62-73.
  • 6Monig SP,Baldus SE,Hennecken JK,et al.Expression of MMP-2 associated with progression and lymph node metastasis of gastric carcinoma.Histopathology,2001,39(4):597-602.
  • 7孙建新,张从昕,殷学平,吴祥甫.重组金属蛋白酶抑制因子-3抗肿瘤作用的实验研究[J].中华肿瘤杂志,1998,20(4):287-289. 被引量:15
  • 8周彩云,姚济芬,陈晓端.基质金属蛋白酶MMP-2、9及其抑制因子TIMP-1、2在子宫颈鳞癌中表达的研究[J].癌症,2002,21(7):735-739. 被引量:26
  • 9黄文斌,朱晓群,史良会,徐国祥,齐琼,林鸿民.大肠癌组织中基质金属蛋白酶-2和基质金属蛋白酶-9的表达[J].临床与实验病理学杂志,2002,18(5):496-498. 被引量:13

共引文献12

同被引文献50

  • 1刘冬玲,李娜萍.MMP-14、VEGF、E-cadherin与子宫颈癌生物学行为的相关性研究[J].华中科技大学学报(医学版),2006,35(6):774-777. 被引量:9
  • 2张亚江,彭诗东.COX-2和CRIPTO-1在喉癌靶向治疗中的应用与展望[J].疾病监测与控制,2012,6(2):80-81. 被引量:1
  • 3刘业海,唐平章,刘芝华,徐震纲,祁永发,李爱东,丁芳,张立勇,骆爱萍.基质金属蛋白酶14基因在人喉鳞状细胞癌中表达差异的分析[J].中华耳鼻咽喉科杂志,2004,39(8):501-506. 被引量:7
  • 4叶冰,彭成.参术胶囊对脾虚胃癌转移鼠胃癌细胞形态影响的研究[J].实验动物科学与管理,2006,23(3):15-18. 被引量:6
  • 5Srivastava P, Lone TA, Kapoor R, et al. Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India[J]. Arch Med Res, 2012,43(2): 117-124.
  • 6Zhang LY,Ren KW. Meta-analysis of MMP2-1306T allele as a protective factor in digestive cancer[J]. Arch Med Res, 2011, 42(3) :239-243.
  • 7Li Y, Sun DL, Duan YN, et al. Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China[J]. Mol Biol Rep, 2010, 37(1) :197-205.
  • 8Rydlova M, Holubec L Jr, Ludvikova M Jr, et al. Biological activity and clinical implications of the matrix metalloproteinases[J]. Anticancer Res, 2008, 28 (2B): 1389- 1397.
  • 9Stetler-Stevenson WG. Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities[J]. Sci Signal, 2008,1 ( 27) : re6.
  • 10Turner NA, Warburton P, O'Regan DJ, et al. Modulatory effect of interleukin-la on expression of structural matrix proteins, MMPs and TIMPs in human cardiac myofibroblasts: role of p38 MAP kinase[J]. Matrix Biol, 2010,29(7) : 613- 620.

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部